AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Embryonic development of multilineage hematopoiesis requires the precisely regulated expression of lineage-specific transcription factors, including AML-1 (encoded by Runx1; also known as CBFA-2 or PEBP-2alphaB). In vitro studies and findings in human diseases, including leukemias, myelodysplastic syndromes and familial platelet disorder with predisposition to acute myeloid leukemia (AML), suggest that AML-1 has a pivotal role in adult hematopoiesis. However, this role has not been fully uncovered in vivo because of the embryonic lethality of Runx1 knockout in mice. Here we assess the requirement of AML-1/Runx1 in adult hematopoiesis using an inducible gene-targeting method. In the absence of AML-1, hematopoietic progenitors were fully maintained with normal myeloid cell development. However, AML-1-deficient bone marrow showed inhibition of megakaryocytic maturation, increased hematopoietic progenitor cells and defective T- and B-lymphocyte development. AML-1 is thus required for maturation of megakaryocytes and differentiation of T and B cells, but not for maintenance of hematopoietic stem cells (HSCs) in adult hematopoiesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The transcription factor RUNX-1 plays a key role in megakaryocyte differentiation and is mutated in cases of myelodysplastic syndrome and leukemia.”
From Differentiation-dependent interactions between RUNX-1 and FLI-1 during megakaryocyte development. (2009) · cites this paper as [18]
In the citing paper
“Conditional knockout studies of mice demonstrate a specific role for RUNX-1 in megakaryocyte differentiation during adult stages of hematopoiesis”
From Differentiation-dependent interactions between RUNX-1 and FLI-1 during megakaryocyte development. (2009) · cites this paper as [18]
In the citing paper
“RUNX-1-deficient megakaryocytes have hypolobulated nuclei, underdeveloped cytoplasm, low DNA ploidy, and enhanced replating activity in semisolid medium culture assays.”
From Differentiation-dependent interactions between RUNX-1 and FLI-1 during megakaryocyte development. (2009) · cites this paper as [18]
Citations
Cites
Identification of Clonogenic Common Lymphoid Progenitors in Mouse Bone Marrow
Kondo, M., Weissman, I. L., & Akashi, K. (1997) · Cell · doi:10.1016/s0092-8674(00)80453-5 · Cited by 2,253 · cited 1×
“1b ), the cells defined by Lin −/lo IL-7Rα + Sca-1 lo c-Kit lo , previously reported to include common lymphocyte progenitors (CLPs”
BackgroundLong-Term Lymphohematopoietic Reconstitution by a Single CD34-Low/Negative Hematopoietic Stem Cell
Osawa, M., Hanada, K.-I., Hamada, H., & Nakauchi, H. (1996) · Science · doi:10.1126/science.273.5272.242 · Cited by 2,140
Okuda, T., van Deursen, J., Hiebert, S. W., Grosveld, G., & Downing, J. R. (1996) · Cell · doi:10.1016/s0092-8674(00)80986-1 · Cited by 1,856
Inducible Gene Targeting in Mice
Kühn, R., Schwenk, F., Aguet, M., & Rajewsky, K. (1995) · Science · doi:10.1126/science.7660125 · Cited by 1,641 · cited 1×
“Here we assess the requirement of AML-1/ Runx1 in adult hematopoiesis using an inducible gene-targeting metho”
MethodWang, Q., Stacy, T., Binder, M., Marin-Padilla, M., Sharpe, A. H., & Speck, N. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3444 · Cited by 1,178
Song, W.-J., Sullivan, M. G., Legare, R. D., Hutchings, S., Tan, X., Kufrin, D., Ratajczak, J., Resende, I. C., Haworth, C., Hock, R., et al. (1999) · Nature Genetics · doi:10.1038/13793 · Cited by 1,100
Transcription Factors, Normal Myeloid Development, and Leukemia
Tenen, D. G., Hromas, R., Licht, J. D., & Zhang, D.-E. (1997) · Blood · doi:10.1182/blood.v90.2.489 · Cited by 735 · cited 1×
“In vitro studies and findings in human diseases, including leukemia”
BackgroundTaniuchi, I., Osato, M., Egawa, T., Sunshine, M. J., Bae, S.-C., Komori, T., Ito, Y., & Littman, D. R. (2002) · Cell · doi:10.1016/s0092-8674(02)01111-x · Cited by 730
Shivdasani, R. A., Fujiwara, Y., McDevitt, M. A., & Orkin, S. H. (1997) · The EMBO Journal · doi:10.1093/emboj/16.13.3965 · Cited by 674
North, T. E., de Bruijn, M. F. T. R., Stacy, T., Talebian, L., Lind, E., Robin, C., Binder, M., Dzierzak, E., & Speck, N. A. (2002) · Immunity · doi:10.1016/s1074-7613(02)00296-0 · Cited by 583
Cited by
Items 401–500 of 595
Beyond BCR::ABL1—The Role of Genomic Analyses in the Management of CML
Branford, S., Fernandes, A., Shahrin, N. H., Maqsood, M., Shanmuganathan, N., & Wadham, C. (2024) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2023.7335 · Cited by 15
“42 , 43 Mutated RUNX1 is rare at CP diagnosis and its clinical relevance at diagnosis is unknown.”
BackgroundYue, F., Zhou, Z., Wang, L., Sun, R., Jiang, Q., Yi, Q., Zhang, T., & Song, L. (2014) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2014.01.008 · Cited by 15
Role of PTPN11 (SHP2) in Cancer
Chan, G., & Neel, B. G. (2016) · Springer eBooks · doi:10.1007/978-1-4939-3649-6_4 · Cited by 14
Hirsutine, a novel megakaryopoiesis inducer, promotes thrombopoiesis via MEK/ERK/FOG1/TAL1 signaling
Kang, Y., Lin, J., Wang, L., Shen, X., Li, J., Wu, A., Yue, L., Wei, L., Ye, Y., Yang, J. Y., et al. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154150 · Cited by 14
Dowdy, C. R., Frederick, D., Zaidi, S. K., Colby, J. L., Lian, J. B., van Wijnen, A. J., Gerstein, R. M., Stein, J. L., & Stein, G. S. (2013) · Experimental Hematology · doi:10.1016/j.exphem.2013.06.006 · Cited by 15
“Megakaryocytic maturation is known to be particularly sensitive to Runx1 [11].”
BackgroundCD45 expression discriminates waves of embryonic megakaryocytes in the mouse
Cortegano, I., Serrano, N., Ruíz, C., Rodríguez, M., Prado, C., Alía, M., Hidalgo, A., Cano, E., de Andrés, B., & Gaspar, M.-L. (2018) · Haematologica · doi:10.3324/haematol.2018.192559 · Cited by 14
“However, RUNX1 is essential for megakaryocyte maturation in the adult BM.(45) Therefore, the fact that EMK in the E11.”
BackgroundJacobs, P. T., Cao, L. H., Samon, J. B., Kane, C. A., Hedblom, E., Bowcock, A. M., & Telfer, J. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069083 · Cited by 14
“It was originally isolated as a regulator of viral enhancers [1,2] as well as the target of chromosomal translocations in human leukemia [3,4], and plays critical roles in hematopoiesis [5–12].”
BackgroundMenter, T., Lundberg, P., Wenzel, F., Dirks, J., Fernandez, P. C., Friess, D., Dirnhofer, S., & Tzankov, A. (2018) · Pathobiology · doi:10.1159/000493688 · Cited by 13
Overexpression ofMIR9indicates poor prognosis in acute lymphoblastic leukemia
Sugita, F., Maki, K., Nakamura, Y., Sasaki, K., & Mitani, K. (2013) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2013.790023 · Cited by 13
Self-citationThe contribution of mouse models to the understanding of constitutional thrombocytopenia
Léon, C., Dupuis, A., Gachet, C., & Lanza, F. (2016) · Haematologica · doi:10.3324/haematol.2015.139394 · Cited by 15
Jayne, N. D., Liang, Z., Lim, D., Chen, P. B., Diaz, C., Arimoto, K., Xia, L., Liu, M., Ren, B., Fu, X., et al. (2024) · Blood Advances · doi:10.1182/bloodadvances.2023011484 · Cited by 13
Systems Biology of Megakaryocytes
Kaushansky, A., & Kaushansky, K. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-2095-2_4 · Cited by 13
“This conclusion was subsequently confirmed by its genetic elimination in mice [93].”
BackgroundRoles of AML 1/ RUNX 1 in T‐cell malignancy induced by loss of p53
Shimizu, K., Yamagata, K., Kurokawa, M., Mizutani, S., Tsunematsu, Y., & Kitabayashi, I. (2013) · Cancer Science · doi:10.1111/cas.12199 · Cited by 16
Self-citationSakai, E., Kitajima, K., Sato, A., & Nakano, T. (2009) · Experimental Hematology · doi:10.1016/j.exphem.2008.11.007 · Cited by 12
“Meanwhile, accumulation of immature HPCs was previously observed in adult conditional Runx1 knockout mice, suggesting that Runx1 plays a role in promoting hematopoietic differentiation [31,32].”
BackgroundHernández-Munaín, C. (2015) · Transcription · doi:10.1080/21541264.2015.1078429 · Cited by 16
“However, conditional Runx1 deficiency in mouse bone marrow cells revealed defective T-lymphocyte development with a significant block in the maturation of DN2 to DN3a thymocytes.(51) Because gd T-lymphocytes can be derived directly from DN2 thymocytes, the failure of Runx1-deficient DN2 thymocytes to generate gd T-cel…”
BackgroundRunx Family Genes in Tissue Stem Cell Dynamics
Wang, C. Q., Mok, M. M. H., Yokomizo, T., Tergaonkar, V., & Osato, M. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-3233-2_9 · Cited by 12
Vukadin, L., Kim, J., Park, E. Y., Stone, J. K., Ungerleider, N., Baddoo, M., Kong, H. K., Richard, A., Tran, J., Giannini, H. K., et al. (2020) · Cancer Gene Therapy · doi:10.1038/s41417-020-00262-9 · Cited by 14
Two faces of RUNX3 in myeloid transformation
Yokomizo‐Nakano, T., & Sashida, G. (2021) · Experimental Hematology · doi:10.1016/j.exphem.2021.02.005 · Cited by 12
Jakobczyk, H., Debaize, L., Soubise, B., Avner, S., Rouger, J., Commet, S., Jiang, Y., Sérandour, A. A., Rio, A.-G., Carroll, J. S., et al. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01051-z · Cited by 14
Cbfβ Reduces Cbfβ-SMMHC–Associated Acute Myeloid Leukemia in Mice
Heilman, S. A., Kuo, Y., Goudswaard, C. S., Valk, P. J. M., & Castilla, L. H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0959 · Cited by 14
Molecular bases of myelodysplastic syndromes: Lessons from animal models
Komeno, Y., Kitaura, J., & Kitamura, T. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21739 · Cited by 14
“AML1 is indispensable for the establishment of definitive hematopoiesis (Okuda et al., 1996; Wang et al., 1996; Ichikawa et al., 2004).”
BackgroundPerspective: chromosomal aneuploidy in leukemia—lessons from down syndrome
Izraeli, S. (2005) · Hematological Oncology · doi:10.1002/hon.758 · Cited by 12
“This rare human syndrome, and other functional studies [19,20] suggest that RUNX1 regulates megakaryopoiesis.”
The mutual regulatory loop between TPTEP1 and miR-1303 in leukemogenesis of acute myeloid leukemia
Li, L., & Zhao, W. (2021) · Cancer Cell International · doi:10.1186/s12935-021-01966-0 · Cited by 11
“Recently, increasing reports have uncovered the increase of aberrant myeloid blasts along with serious blockage in myeloid differentiation are the primary signs of AML [3, 4].”
BackgroundWong, W. F., Kohu, K., Nagashima, T., Funayama, R., Matsumoto, M., Movahed, E., Tan, G. M. Y., Yeow, T. C., Looi, C. Y., Kurokawa, M., et al. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2015.08.012 · Cited by 11
Self-citationMaki, K., Sasaki, K., Sugita, F., Nakamura, Y., & Mitani, K. (2012) · International Journal of Hematology · doi:10.1007/s12185-012-1112-z · Cited by 12
Self-citationCorrection: SARS Coronavirus 3b Accessory Protein Modulates Transcriptional Activity of RUNX1b
Varshney, B., Agnihothram, S., Tan, Y., Baric, R. S., & Lal, S. K. (2012) · PLoS ONE · doi:10.1371/annotation/64ae6047-0f9b-4d17-a065-e08c153aa435 · Cited by 11
Pin1‐Mediated Prolyl Isomerization of Runx1 Affects PU.1 Expression in Pre‐Monocytes
Islam, R., Yoon, W., Woo, K. M., Baek, J., & Ryoo, H. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24462 · Cited by 11
Giguère, A., & Hébert, J. (2013) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22105 · Cited by 11
“2009) while also acting as master regulator of megakaryocytic, lymphoid and myeloid differentiation in adults through the activation or repression of lineage-specific genes (Ichikawa et al., 2004).”
BackgroundMok, M. M. H., Du, L., Wang, C. Q., Tergaonkar, V., Liu, T. C., Kham, S. K. Y., Sanda, T., Yeoh, A. E. J., & Osato, M. (2014) · Gene · doi:10.1016/j.gene.2014.04.074 · Cited by 11
“Perturbations in Runx1 in mice have previously been shown to impair T-cell development at double-negative thymocyte stage (Ichikawa et al., 2004).”
BackgroundAML1 enhances the expression of leukotriene B 4 type‐1 receptor in leukocytes
Hashidate, T., Murakami, N., Nakagawa, M. M., Ichikawa, M., Kurokawa, M., Shimizu, T., & Nakamura, M. (2010) · The FASEB Journal · doi:10.1096/fj.10-156844 · Cited by 10
“On the basis of our findings, we propose that the facilitation of BLT1 expression requires chromatin remodeling of AE-BLex, because AML1 is widely expressed in cells of hematopoietic lineage, including naive T cells (17, 19, 37).”
BackgroundMethodSelf-citationAdvances in B-lymphoblastic leukemia: cytogenetic and genomic lesions
Zhou, Y., Kanagal‐Shamanna, R., Zuo, Z., Tang, G., Medeiros, L. J., & Bueso-Ramos, C. (2016) · Annals of Diagnostic Pathology · doi:10.1016/j.anndiagpath.2016.02.002 · Cited by 11
“RUNX1, located on 21q22, is a transcription factor that is required for hematopoietic development at an early embryonic stage as well as for T- and B-cell differentiation during hematopoiesis in adults [2].”
BackgroundMolecular Pathogenesis of BCR-ABL-Negative Atypical Chronic Myeloid Leukemia
Fontana, D., Gambacorti-Passerini, C. B., & Piazza, R. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.756348 · Cited by 11
“It is also reported to interact with the Runx1 promoter, resulting in Runx1 downregulation (89) and impairment of the Runx1-dependent program of myeloid differentiation (90, 91).”
BackgroundHämmerling, S., Behnisch, W., Doerks, T., Korbel, J. O., Bork, P., Moog, U., Hentze, S., Grasshoff, U., von Bonin, M., Rieß, O., et al. (2012) · British Journal of Haematology · doi:10.1111/j.1365-2141.2012.09028.x · Cited by 10
“It is unknown which gene products encoded by chromosome 21 are functionally important but the transcription factors RUNX1 and BACH1 are candidates, because they are known to play a role in megakaryopoiesis (Ichikawa et al, 2004; Toki et al, 2005).”
BackgroundCDK9 phosphorylates RUNX1 to promote megakaryocytic fate in megakaryocytic-erythroid progenitors
Kwon, N., Lu, Y.-C., Thompson, E. N., Mancuso, R. I., Wang, L., Zhang, P.-X., & Krause, D. S. (2024) · Blood · doi:10.1182/blood.2024023963 · Cited by 10
Ahmad, M. H., Hegde, M., Wong, W. J., Mohammadhosseini, M., Garrett, L. J., Carrascoso, A., Issac, N. G., Ebert, B. L., Silva, J. C., Pihan, G. A., et al. (2023) · Blood Advances · doi:10.1182/bloodadvances.2023010398 · Cited by 10
Yamamoto, K. Y., Tsuzuki, S., Minami, Y., Yamamoto, Y., Abe, A., Ohshima, K., Seto, M., & Naoe, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074864 · Cited by 9
“These findings imply that impaired AML1 functions may enhance self-renewal of progenitor cells and block their differentiation, thus priming the cells for leukemic transformation [7,8,20].”
BackgroundAppelmann, I., Linden, T., Rudat, A., Müller‐Tidow, C., Berdel, W. E., & Mesters, R. M. (2009) · Annals of Hematology · doi:10.1007/s00277-009-0722-x · Cited by 9
“Additionally, the AML1 gene is important for megakaryocyte development [9].”
BackgroundSERPINB13 is a novel RUNX1 target gene
Boyapati, A., Ren, B., & Zhang, D. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.06.107 · Cited by 9
“RUNX1 is essential during development [5; 6] and conditional knockout of RUNX1 revealed that it is critical for the development of platelets and T-cells [7; 8].”
BackgroundJenkins, C. E., Gusscott, S., Wong, R. J., Shevchuk, O. O., Rana, G., Giambra, V., Tyshchenko, K., Islam, R., Hirst, M., & Weng, A. P. (2018) · Experimental Hematology · doi:10.1016/j.exphem.2018.04.008 · Cited by 9
Mascarenhas, C. D. C., da Cunha, A. F., Brugnerotto, A. F., Gambero, S., Almeida, M. H., Carazzolle, M. F., Pagnano, K. B. B., Traina, F., Costa, F. F., & Souza, C. A. D. (2013) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2013.855311 · Cited by 9
Canonical BAF complex regulates the oncogenic program in human T-cell acute lymphoblastic leukemia
Aoki, K., Hyuga, M., Tarumoto, Y., Nishibuchi, G., Ueda, A., Ochi, Y., Sugino, S., Mikami, T., Kobushi, H., Kato, I., et al. (2023) · Blood · doi:10.1182/blood.2023020857 · Cited by 10
Self-citationYoshida, T., Yamasaki, K., Tadagaki, K., Kuwahara, Y., Matsumoto, A., Sofovic, A., Kondo, N., Sakai, T., & Okuda, T. (2021) · International Journal of Oncology · doi:10.3892/ijo.2021.5296 · Cited by 9
“Further analyzes suggested that RUNX1 is also a regulator of T‐cell activation (16,17).”
BackgroundMegakaryopoiesis and Thrombopoiesis
Kowata, S., & Ishida, Y. (2017) · Springer eBooks · doi:10.1007/978-981-10-4142-6_2 · Cited by 10
Tachibana, M., Tezuka, C., Muroi, S., Nishimoto, S., Katsumoto, T., Nakajima, A., Kitabayashi, I., & Taniuchi, I. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.01.124 · Cited by 8
Tyrosyl phosphorylation toggles a Runx1 switchPreprint
Neel, B. G., & Speck, N. A. (2012) · Genes & Development · doi:10.1101/gad.198051.112 · Cited by 7
Roles of RUNX in B Cell Immortalisation
West, M. J., & Farrell, P. J. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-3233-2_18 · Cited by 8
“The bone marrow of adult mice lacking functional Runx1 showed impaired megakaryocytic maturation and defective T- and B-lymphocyte development (Ichikawa et al. 2004).”
BackgroundMarín‐Quilez, A., García‐Tuñón, I., Fernández-Infante, C., Hernández-Cano, L., Palma‐Barqueros, V., Vuelta, E., Sánchez‐Martín, M., González-Porras, J. R., Guerrero, C., Benito, R., et al. (2021) · Thrombosis and Haemostasis · doi:10.1055/s-0041-1723987 · Cited by 8
Transcriptional repressors, corepressors and chromatin modifying enzymes in T cell development
Shapiro, M. J., & Shapiro, V. S. (2010) · Cytokine · doi:10.1016/j.cyto.2010.11.013 · Cited by 14
Adult Stem Cel Diferentiation and Trafficking And Their Implications in Disease
Zhuge, Y., Liu, Z., & Velazquez, O. C. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-7037-4_12 · Cited by 7
Diagnosis and Classification of AML: WHO 2016
Voso, M. T., Bellis, E. D., & Ottone, T. (2021) · Hematologic malignancies · doi:10.1007/978-3-030-72676-8_2 · Cited by 8
CEMIG: prediction of the cis-regulatory motif using the de Bruijn graph from ATAC-seq
Wang, Y., Li, Y., Wang, C., Lio, C. J., Ma, Q., & Liu, B. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad505 · Cited by 6
“It is crucial for B cell homeostasis and differentiation [42, 43].”
BackgroundInterface-guided phenotyping of coding variants in the transcription factor RUNX1
Öztürk, K., Panwala, R., Sheen, J., Ford, K. M., Jayne, N. D., Portell, A. J., Zhang, D., Hütter, S., Haferlach, T., Ideker, T., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114436 · Cited by 11
“42 44–46 It plays an important role in T lymphocyte development and lineage specification 47 and megakaryocyte differentiation, 47,48 and it is implicated in erythroid cell differentiation.”
BackgroundMolecular Testing in Patients with Suspected Myelodysplastic Syndromes
Moyo, T. K., & Savona, M. R. (2016) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-016-0356-8 · Cited by 9
Zhou, X., Wei, Y., Chen, P., Yang, X., Lu, C., & Pan, M. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.124931 · Cited by 8
Liu, H., Cui, Y. T., Wang, G., Dong, Q., Yao, Y., Li, P., Cao, C., & Liu, X. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2018.05.001 · Cited by 8
Tornack, J., Seiler, K., Grützkau, A., Grün, J. R., Onodera, M., Melchers, F., & Tsuneto, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070116 · Cited by 6
“For example, Tal-1 is required for proper differentiation of erythroid and megakaryocytic cells [14], and Runx1 is required in B and T lymphocyte development [54–58].”
BackgroundIn vivo CRISPR screening identifies SAGA complex members as key regulators of hematopoiesis
Shankar, A., Olender, L., Hsu, I., Miyauchi, M., Pálovics, R., Meaker, G. A., Kaito, S., Rizq, O., Khoo, H. M., Bozhilov, Y. K., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-68465-6 · Cited by 16
“In our pairwise analysis however, we observed relative loss of Runx1 sgRNAs in all lineages includingmyeloid 26,27 (SupplementaryFig.”
The poly(C)-binding protein Pcbp2 is essential for CD4+ T cell activation and proliferation
Martinelli, M., Aguilar, G., Lee, D. S. M., Kromer, A., Nguyen, N., Wilkins, B. J., Akimova, T., Beier, U. H., & Ghanem, L. R. (2022) · iScience · doi:10.1016/j.isci.2022.105860 · Cited by 7
“Runx1 is a master hematopoietic transcriptional factor with a well-documented role in the expansion and maintenance of lymphoid and platelet populations.(31,33,48,49) Thus, we investigated the possibility that changes in Runx1 expression or isoform abundance could be associated with decreases in peripheral CD4 CKO lym…”
BackgroundAdhesion to fibronectin induces megakaryocytic differentiation of JAS-REN cells.
Yamada, H., Sekikawa, T., Agawa, M., Iwase, S., Suzuki, H., & Horiguchi‐Yamada, J. (2008) · PubMed · Cited by 5
Molecular and Cellular Biology of Platelet Formation: Implications in Health and Disease
Italiano, J. E., & Schulze, H. (2016) · Springer eBooks · doi:10.1007/978-3-319-39562-3 · Cited by 8
Choosing wisely: RUNX1 alternate promoter use
Cantor, A. B. (2017) · Blood · doi:10.1182/blood-2017-06-786228 · Cited by 5
The RUNX1 Enhancer Element eR1: A Versatile Marker for Adult Stem Cells.
Chuang, L. S. H., Osato, M., & Ito, Y. (2020) · PubMed Central · doi:10.14348/molcells.2019.0250 · Cited by 7
“Mx1-Cre conditional knockout of Runx1 in bone marrow resulted in increased hematopoietic stem/progenitor cell (HSPC) pool as well as a block in development of megakaryocyte, T- and B-lymphocytes (Growney et al., 2005; Ichikawa et al., 2004).”
BackgroundPrecocious Phenotypic Transcription‐Factor Expression During Early Development
VanOudenhove, J., Medina, R., Ghule, P. N., Lian, J. B., Stein, J. L., Zaidi, S. K., & Stein, G. S. (2016) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25723 · Cited by 5
Peng, W., Merlo, L. M. F., Grabler, S., Montgomery, J. D., & Mandik‐Nayak, L. (2024) · The Journal of Immunology · doi:10.4049/jimmunol.2400445 · Cited by 3
Dominant Negative Effects of the AML1/ETO Fusion Oncoprotein
Fenske, T. S., Pengue, G., & Graubert, T. A. (2004) · Cell Cycle · doi:10.4161/cc.4.1.1399 · Cited by 5
“The t(8;21) is likely an early event in the pathogenesis of AML.”
BackgroundMethodInfluentialYamada, H., Sekikawa, T., Iwase, S., Arakawa, Y., Suzuki, H., Agawa, M., Akiyama, M., Takeda, N., & Horiguchi‐Yamada, J. (2007) · Leukemia Research · doi:10.1016/j.leukres.2007.02.005 · Cited by 5
Transcription Factors Runx1 and Runx3 Suppress Keratin Expression in Undifferentiated Keratinocytes
Ogawa, E., Edamitsu, T., Ohmori, H., Kohu, K., Kurokawa, M., Kiyonari, H., Satake, M., & Okuyama, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231710039 · Cited by 4
“We used K5Cre-transgenic mice [22], Runx1-flox/flox (Runx1 fl/fl) mice [23], and Runx3-flox/flox (Runx3 fl/fl) mice (these mice were generated in this study, see MATERIALS and METHODS section), which were crossed to obtain K5Cre-Runx1 fl/fl mice and K5Cre-Runx3 fl/fl mice.”
BackgroundMethodSelf-citationPapadantonakis, N., & Ravid, K. (2009) · Springer eBooks · doi:10.1007/978-0-387-85816-6_5 · Cited by 6
Multiomic Data Integration Reveals Microbial Drivers of Aetiopathogenesis in Mycosis FungoidesPreprint
Licht, P., & Mailänder, V. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.01.15.575621 · Cited by 4
Safdari, S. M., Jozdani, S., Mottaghizadeh-Jazi, M., Shayanmanesh, M., Khanahmad, A., Bakhtiyaridovvombaygi, M., Rezazadeh, A., & Tabibian, S. (2025) · Thrombosis Journal · doi:10.1186/s12959-025-00797-7 · Cited by 3
Jassinskaja, M., & Hansson, J. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.824098 · Cited by 3
“, 1996), while adult Runx1-deficient HSCs exhibit differentiation defects but are viable (Ichikawa et al., 2004).”
BackgroundAcute megakaryoblastic leukemia and loss of the RUNX1 gene
Berger, R., Busson, M., Dastugue, N., Radford‐Weiss, I., Michaux, L., Hagemeijer, A., Quilichini, B., Benattar, L. K., Bernard, O., & Romana, S. P. (2005) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2005.05.002 · Cited by 3
Principles of Hematopoietic Stem Cell Biology
Ema, H., Kobayashi, T., & Nakauchi, H. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-347-3_1 · Cited by 3
RUNX/CBF Transcription Factors☆
Lam, K., & Zhang, D. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.98749-x · Cited by 3
Congenital and Acquired Disorders of Platelet Function and Number
Jobe, S. M., & Paola, J. D. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-46202-0.00009-1 · Cited by 5
Mouse models of diseases of megakaryocyte and platelet homeostasis
Carmichael, C., & Alexander, W. S. (2011) · Mammalian Genome · doi:10.1007/s00335-011-9336-4 · Cited by 4
“oped DMS, resembling the micromegakaryocytes found in human myelodysplastic syndrome (Ichikawa et al. 2004).”
BackgroundInfluentialMolecular genetics of acute myeloid leukemia
Gruber, T. A., & Downing, J. R. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511977633.009 · Cited by 3
Molecular genetics of acute myeloid leukemia
Lorsbach, R. B., & Downing, J. R. (2006) · Cambridge University Press eBooks · doi:10.1017/cbo9780511471001.012 · Cited by 4
Down's syndrome as a model of a pre-leukemic condition.
Izraeli, S. (2006) · PubMed · Cited by 3
Transcriptional factor RUNX1: A potential therapeutic target for fibrotic pulmonary disease
LIU, J., WANG, F., YUAN, B., & Luo, F. (2023) · Biocell · doi:10.32604/biocell.2023.026148 · Cited by 3
Runt-related transcription factors in human carcinogenesis: a friend or foe?
Roy, A., Chauhan, S., Bhattacharya, S., Jakhmola, V., Tyagi, K., Sachdeva, A., Wasai, A., & Mandal, S. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-04769-0 · Cited by 3
“A recent study has shown that downregulation of Runx1 leads to the leukemic transformation of hematopoietic progenitor cells along with altering their self-renewal capacities (Ichikawa et al. 2004).”
BackgroundAn Isoform-Specific RUNX1C–BTG2 Axis Governs AML Quiescence and Chemoresistance
Han, C., Zhang, Z., Crosse, E. I., Sajedi, S., Lü, B., Wang, X., Karma, S., Kostich, M. S., Rajendran, S. H., Udy, D. B., et al. (2025) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-24-0327 · Cited by 3
“Previous studies have shown that RUNX1 is crucial for blood cells (12); however, it is dispensable for adult hematopoiesis (13, 60).”
Runx1/AML1 is a Guardian of Hematopoietic Stem Cells
Motoda, L., Osato, M., & Ito, Y. (2008) · Current Cancer Therapy Reviews · doi:10.2174/157339408785294302 · Cited by 2
“Conditional knockout mice have recently revealed the role of Runx1 in adult hematopoiesis [7-10].”
BackgroundProduction plaquettaire : régulation cellulaire et moléculaire
Cramer, E. M. (2008) · Encyclopédie médico-chirurgicale. Hématologie · doi:10.1016/s1155-1984(08)42129-5 · Cited by 5
YiYing, L. I. U., Ma, F., CuiCui, L. I. U., Wu, D., Su, P., YuQi, W. E. N., HongTao, W. A. N. G., Shi, L., JiaXi, Z. H. O. U., & Tu, Q. (2017) · Scientia Sinica Vitae · doi:10.1360/n052017-00270 · Cited by 2
The Cellular and Molecular Mechanisms of Hematopoiesis
Rankin, E. B., & Sakamoto, K. M. (2018) · Pediatric oncology · doi:10.1007/978-3-319-61421-2_1 · Cited by 3
Expression of Evi-1 Gene in Leukaemia: Diagnostic and Prognostic Perspective
Okafor, I. M., & Okoroiwu, H. U. (2021) · Annual Research & Review in Biology · doi:10.9734/arrb/2021/v36i130337 · Cited by 4
Congenital and Acquired Disorders of Platelet Function and Number
Jobe, S. M., & Paola, J. D. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-2296-9.00010-5 · Cited by 3
Ernst, M. P. T., Pronk, E., van Dijk, C., van Strien, P. M. H., van Tienhoven, T. V. D., Wevers, M. J. W., Sanders, M. A., Bindels, E. M., Speck, N. A., & Raaijmakers, M. H. G. P. (2023) · HemaSphere · doi:10.1097/hs9.0000000000000824 · Cited by 3
Ernst, P. (2009) · Springer eBooks · doi:10.1007/978-0-387-85816-6_1 · Cited by 3
Tijssen, M. R., Moreau, T., & Ghevaert, C. (2016) · Springer eBooks · doi:10.1007/978-3-319-39562-3_2 · Cited by 5
“However, using a murine Mx-Cre conditional system which allows the deletion of Runx1 from adult haematopoiesis, a clear role for RUNX1 was shown for the development of lymphocytes and MKs, whilst myelopoiesis and HSC function were preserved [99], similar to what is observed for TAL1.”
ResultLiu, H. (2005) · DiVA (Digitala Vetenskapliga Arkivet) · Cited by 2
Transcription Factors Responsible for Megakaryocyte-specific Gene Expression
Doi, T. (2005) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.125.685 · Cited by 2
RUNX1 isoform disequilibrium in the development of trisomy 21 associated myeloid leukemiaPreprint
Gialesaki, S., Bräuer-Hartmann, D., Bhayadia, R., Alejo-Valle, O., Issa, H., Regényi, E., Beyer, C., Labuhn, M., Ihling, C. H., Sinz, A., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.03.07.483334 · Cited by 2
“These findings are in line with the known function of RUNX1C during adult hematopoiesis (Growney et al., 2005; Ichikawa et al., 2004; Senserrich et al., 2018), where it regulates megakaryopoiesis by controlling the proliferation and survival of committed progenitors (Draper et al.”
ResultBai, J., Araki, K., Kurotaki, D., Eerdunduleng, Sorin, S., Hiramatsu, K., Uno, N., Hamashima, A., Iimori, M., Kikuchi, K., et al. (2026) · Oncogene · doi:10.1038/s41388-026-03763-3 · Cited by 1
Kamel, E. M., Khadrawy, S. M., Ali, M. A. M., Ahmed, N. A., Alkhedhairi, S., Alkhayl, F. F. A., & Lamsabhi, A. M. (2026) · Discover Oncology · doi:10.1007/s12672-026-05066-1 · Cited by 1
“A defining feature of HSCs is their capacity to divide either symmetrically, producing additional HSCs, or asymmetrically, generating progenitors that sustain multilineage hematopoiesis [13, 14].”
Kamel, E. M., Khadrawy, S. M., Ali, M. A. M., Ahmed, N. A., Alkhedhairi, S., Alkhayl, F. F. A., & Lamsabhi, A. M. (2026) · Pathology - Research and Practice · doi:10.1016/j.prp.2026.156607 · Cited by 1
Lineage-Specific Transcription Factor Aberrations in AML
Mueller, B. U., & Pabst, T. (2009) · Cancer treatment and research · doi:10.1007/978-0-387-69259-3_7 · Cited by 3
“However, recent studies using conditional knockout mice showed that AML1/RUNX1 and SCL/Tal-1 are less critical for the maintenance of HSCs in the adult organism [21, 28 ], indicating that these nuclear factors may be required for the generation of HSCs from more pluripotent cells in the embryo but not for HSC selfrene…”
BackgroundTranscription Factors in Cancer Stem Cells of the Hematopoietic Lineage
Koschmieder, S., & Tenen, D. G. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-933-8_6 · Cited by 1
AML-1 steps up to the platelets
Irvin, B. J., & Hiebert, S. W. (2004) · Nature Medicine · doi:10.1038/nm0304-238 · Cited by 1
Metadata
- Authors
- Ichikawa, M., Asai, T., Saito, T., Yamamoto, G., Seo, S., Yamazaki, I., Yamagata, T., Mitani, K., Chiba, S., Hirai, H., Ogawa, S., & Kurokawa, M.
- Affiliations
- The University of Tokyo (JP)
- Inoue Hospital (JP)
- Joslin Diabetes Center (US)
- Dokkyo University (JP)
- Corresponding author
- Ogawa, Seishi
- ORCID
- Venue
- Nature Medicine
- Published
- 2004-02-15
- Volume
- 10
- Issue
- 3
- Pages
- 299-304
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2101518963
- Cited by
- 596
- References
- 29
- Citations by year
- 2026: 11 · 2025: 5 · 2024: 10 · 2023: 12 · 2022: 16 · 2021: 28 · 2020: 18 · 2019: 22 · 2018: 20 · 2017: 33 · 2016: 26 · 2015: 23 · 2014: 24 · 2013: 29 · 2012: 27
- FWCI
- 30.73
- Type
- journal article
- Language
- en
- Update notices
- erratum (2005-01-01)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Keywords
- RUNX1, lymphocyte differentiation, T cell development, B cell development, hematopoietic stem cells, hematopoietic progenitor cells, adult hematopoiesis, myelodysplastic syndrome
- MeSH terms
- Adult, Animals, Bone Marrow Cells, Cell Differentiation, DNA-Binding Proteins, Hematopoiesis, Hematopoietic Stem Cells, Humans, Lymphocytes, Megakaryocytes, Mice, Inbred Strains, Mice, Transgenic, Proto-Oncogene Proteins, Transcription Factors, Gene Targeting, Cell Lineage, Cell Size, Core Binding Factor Alpha 2 Subunit, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.